Sign In
Buy LQDA
$55.69
+0.580 (+1.05%)
At Close: Jun 03, 2026
Is Liquidia Technologies (NASDAQ:LQDA) Using Debt In A Risky Way?
12:20pm, Tuesday, 16'th Jun 2020
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Do Hedge Funds Love Liquidia Technologies, Inc. (LQDA)?
11:09pm, Friday, 12'th Jun 2020
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F
Patent Filings Roundup: WSOU Entity Leads Sustained Spike in District Court Filings, Sandoz Takes a Shot at Novo Nordisk’s Insulin treatment
04:15pm, Wednesday, 10'th Jun 2020
District court filings remained unusually high this week (97), with 40 Patent Trial and Appeal Board (PTAB) cases filed (one Covered Business Method, one Post Grant Review, and 38 Inter Partes Reviews
Liquidia Responds to United Therapeutics Corporation Lawsuit Alleging Infringement of Tyvaso Patents
07:30pm, Friday, 05'th Jun 2020
Liquidia Technologies, Inc. (LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, to
Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne
02:31pm, Friday, 29'th May 2020
Zacks.com featured highlights include: Minerva Neurosciences, Liquidia Technologies, Calix, Avenue Therapeutics and ExOne
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
12:00am, Friday, 29'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 28)
ADC Therapeutics SA (NYSE:...
5 Stocks With Recent Price Strength to Tap Wall Street Rally
11:53am, Thursday, 28'th May 2020
Investors target stocks that are witnessing a bullish run. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Liquidia to Present at the Jefferies Virtual Healthcare Conference
12:04am, Thursday, 28'th May 2020
Liquidia Technologies, Inc. (LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, to
Xconomy: Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More
02:40pm, Friday, 22'nd May 2020
As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists
Why Liquidia Technologies (LQDA) Stock Might be a Great Pick?
02:01pm, Friday, 22'nd May 2020
Liquidia Technologies (LQDA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer
11:15am, Monday, 18'th May 2020
Liquidia Technologies, Inc. (LQDA), a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel products utilizing its proprietary PRINT® technology, to
Liquidia Technologies' (LQDA) CEO Neal Fowler on Q1 2020 Results - Earnings Call Transcript
02:32am, Tuesday, 12'th May 2020
Liquidia Technologies, Inc. (NASDAQ:LQDA) Q1 2020 Earnings Conference Call May 11, 2020 4:30 PM ET Company Participants Jason Adair – Vice President, Corporate
Liquidia Reports First Quarter 2020 Financial Results and Provides Corporate Update
08:01pm, Monday, 11'th May 2020
Received FDA Acceptance of LIQ861 NDA for ReviewReported Final Safety and Tolerability Results for LIQ861 Inspire TrialManagement to Host Webcast and Conference Call Today at.
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
12:00am, Sunday, 10'th May 2020
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB)...
These 3 Biotech Stocks Have Massive Upside Potential, Says Wedbush
01:30pm, Thursday, 07'th May 2020
Take your eye off the ball, and you might have just missed a home run. Veteran players of the stock picking game know that biotechs are capable of delivering a win at what feels like the drop of a hat
